1. Home
  2. NKTX vs AMTX Comparison

NKTX vs AMTX Comparison

Compare NKTX & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • AMTX
  • Stock Information
  • Founded
  • NKTX 2015
  • AMTX 2005
  • Country
  • NKTX United States
  • AMTX United States
  • Employees
  • NKTX N/A
  • AMTX N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • AMTX Major Chemicals
  • Sector
  • NKTX Health Care
  • AMTX Industrials
  • Exchange
  • NKTX Nasdaq
  • AMTX Nasdaq
  • Market Cap
  • NKTX 123.5M
  • AMTX 125.1M
  • IPO Year
  • NKTX 2020
  • AMTX N/A
  • Fundamental
  • Price
  • NKTX $1.80
  • AMTX $2.94
  • Analyst Decision
  • NKTX Strong Buy
  • AMTX Strong Buy
  • Analyst Count
  • NKTX 6
  • AMTX 4
  • Target Price
  • NKTX $14.40
  • AMTX $13.63
  • AVG Volume (30 Days)
  • NKTX 434.5K
  • AMTX 1.5M
  • Earning Date
  • NKTX 08-12-2025
  • AMTX 07-31-2025
  • Dividend Yield
  • NKTX N/A
  • AMTX N/A
  • EPS Growth
  • NKTX N/A
  • AMTX N/A
  • EPS
  • NKTX N/A
  • AMTX N/A
  • Revenue
  • NKTX N/A
  • AMTX $237,892,000.00
  • Revenue This Year
  • NKTX N/A
  • AMTX $27.78
  • Revenue Next Year
  • NKTX N/A
  • AMTX $91.59
  • P/E Ratio
  • NKTX N/A
  • AMTX N/A
  • Revenue Growth
  • NKTX N/A
  • AMTX N/A
  • 52 Week Low
  • NKTX $1.31
  • AMTX $1.22
  • 52 Week High
  • NKTX $8.23
  • AMTX $4.73
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 51.45
  • AMTX 78.87
  • Support Level
  • NKTX $1.68
  • AMTX $2.03
  • Resistance Level
  • NKTX $1.84
  • AMTX $3.66
  • Average True Range (ATR)
  • NKTX 0.08
  • AMTX 0.21
  • MACD
  • NKTX 0.01
  • AMTX 0.10
  • Stochastic Oscillator
  • NKTX 80.95
  • AMTX 80.37

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: